Drew Janice Suzann
Reporting owner on Forms 3, 4 and 5, CIK 2091053.
Drew Janice Suzann reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Evommune, Inc. CIK 2044725 | officer (Chief of Dev. Operations) | 1 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | D returned to the issuer | -231,274 | 0 | Form 4 | |
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | A granted | +231,274 | 231,274 | Form 4 | |
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | D returned to the issuer | -73,892 | 0 | Form 4 | |
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | A granted | +73,892 | 73,892 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002091053-26-000007 | Evommune, Inc. | 2026-11-17 |